Department of Pharmaceutical Chemistry, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.
College of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, China.
Int J Mol Sci. 2019 May 31;20(11):2690. doi: 10.3390/ijms20112690.
Tuberculosis (TB) is one of the top infectious diseases causing numerous human deaths in the world. Despite enormous efforts, the physiology of the causative agent, , is poorly understood. To contribute to better understanding the physiological capacity of these microbes, we have carried out extensive in silico analyses of the 1111 mycobacterial species genomes focusing on revealing the role of the orphan cytochrome P450 monooxygenase (CYP) CYP139 family. We have found that CYP139 members are present in 894 species belonging to three mycobacterial groups: complex (850-species), complex (34-species), and non-tuberculosis mycobacteria (10-species), with all CYP139 members belonging to the subfamily "A". CYP139 members have unique amino acid patterns at the CXG motif. Amino acid conservation analysis placed this family in the 8th among CYP families belonging to different biological domains and kingdoms. Biosynthetic gene cluster analyses have revealed that 92% of CYP139As might be associated with producing different secondary metabolites. Such enhanced secondary metabolic potentials with the involvement of CYP139A members might have provided mycobacterial species with advantageous traits in diverse niches competing with other microbial or viral agents, and might help these microbes infect hosts by interfering with the hosts' metabolism and immune system.
结核病(TB)是世界上导致大量人类死亡的主要传染病之一。尽管付出了巨大努力,但对病原体的生理学仍了解甚少。为了更好地了解这些微生物的生理能力,我们对 1111 种分枝杆菌物种的基因组进行了广泛的计算机分析,重点揭示了孤儿细胞色素 P450 单加氧酶(CYP)CYP139 家族的作用。我们发现,CYP139 成员存在于属于三个分枝杆菌群的 894 个物种中:复合群(850 个物种)、复合群(34 个物种)和非结核分枝杆菌(10 个物种),所有 CYP139 成员都属于“ A”亚科。CYP139 成员在 CXG 基序处具有独特的氨基酸模式。氨基酸保守性分析将该家族置于不同生物域和王国的 CYP 家族中的第 8 位。生物合成基因簇分析表明,92%的 CYP139As 可能与产生不同的次生代谢物有关。涉及 CYP139A 成员的这种增强的次生代谢潜力可能为分枝杆菌物种在与其他微生物或病毒剂竞争的不同小生境中提供了有利的特征,并可能通过干扰宿主的新陈代谢和免疫系统来帮助这些微生物感染宿主。